Clinical Trials Browser

Phase 2 × Ovarian Cancer Recurrent × 1-dodecylpyridoxal × Clear all

NCT06014528 2025-04-30

IN10018 in Combination With Pegylated Liposomal Doxorubicin (PLD) vs. Placebo in Combination With PLD for the Treatment of Platinum-resistant Recurrent Ovarian Cancer

Phase 2 Recruiting

Ovarian Cancer Recurrent